Key Details
Price
$0.84Annual ROE
-201.87%Beta
1.19Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 28, 2025Recent annual earnings:
Feb 28, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 15, 25 D. Boral Capital
BuyJan 8, 25 JMP Securities
Market OutperformNov 25, 24 D. Boral Capital
BuySep 23, 24 HC Wainwright & Co.
BuySep 16, 24 HC Wainwright & Co.
BuyJul 10, 24 HC Wainwright & Co.
BuyMay 16, 24 Piper Sandler
OverweightMay 9, 24 Maxim Group
BuyMay 9, 24 HC Wainwright & Co.
BuyMar 21, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Context Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Context Therapeutics?
- Does Context Therapeutics pay dividends?
- What sector is Context Therapeutics in?
- What industry is Context Therapeutics in?
- What country is Context Therapeutics based in?
- When did Context Therapeutics go public?
- Is Context Therapeutics in the S&P 500?
- Is Context Therapeutics in the NASDAQ 100?
- Is Context Therapeutics in the Dow Jones?
- When was Context Therapeutics's last earnings report?
- When does Context Therapeutics report earnings?
- Should I buy Context Therapeutics stock now?
What is the ticker symbol for Context Therapeutics?
The ticker symbol for Context Therapeutics is NASDAQ:CNTX
Does Context Therapeutics pay dividends?
No, Context Therapeutics does not pay dividends
What sector is Context Therapeutics in?
Context Therapeutics is in the Healthcare sector
What industry is Context Therapeutics in?
Context Therapeutics is in the Biotechnology industry
What country is Context Therapeutics based in?
Context Therapeutics is headquartered in United States
When did Context Therapeutics go public?
Context Therapeutics's initial public offering (IPO) was on October 20, 2021
Is Context Therapeutics in the S&P 500?
No, Context Therapeutics is not included in the S&P 500 index
Is Context Therapeutics in the NASDAQ 100?
No, Context Therapeutics is not included in the NASDAQ 100 index
Is Context Therapeutics in the Dow Jones?
No, Context Therapeutics is not included in the Dow Jones index
When was Context Therapeutics's last earnings report?
Context Therapeutics's most recent earnings report was on Feb 28, 2025
When does Context Therapeutics report earnings?
The date for Context Therapeutics's next earnings report has not been announced yet
Should I buy Context Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions